N
Nomiair Medical Technology
Regenerative implantable medical devices for tissue repair using advanced 3D electrospinning technology
About Nomiair Medical Technology
Neo Modulus, founded in March 2017 by Chinese and German scientists, focuses on the research, development, production, and commercialization of regenerative implantable medical devices. The company operates in the medical device market, specifically targeting tissue regeneration and repair. Utilizing advanced 3D electrospinning technology, Neo Modulus builds scaffold structures that facilitate tissue regeneration through principles such as hydrogen bonding, electrostatic attraction, and mechanical force. These scaffolds are characterized by their mechanical strength, bioactivity, degradability, and histocompatibility. Neo Modulus collaborates with top scientific research institutes and scientists to make breakthroughs in materials, techniques, and equipment, addressing global challenges in tissue restoration and organ reconstruction. The business model revolves around academic cooperation and commercialization of its innovative products, generating revenue through the sale of its medical devices. The company serves healthcare providers and research institutions seeking advanced solutions for tissue repair and regeneration.
Source: Dealroom company dataNews
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES C✓Equity / VC | Jan 2025 | $41M | $165M | Shenzhen Capital Group | ↗ |
Growth signals
Latest recorded traffic for Nomiair Medical Technology is 920 monthly website visits, up 922.2% over the last three months.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Nomiair Medical Technology in its local ecosystem
The Nomiair Medical Technology office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later1 investor entered at this stage
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Nomiair Medical Technology on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Nomiair Medical Technology’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.









